PE20121326A1 - Derivados de anillo heterociclico fusionado y uso del mismo - Google Patents

Derivados de anillo heterociclico fusionado y uso del mismo

Info

Publication number
PE20121326A1
PE20121326A1 PE2012000255A PE2012000255A PE20121326A1 PE 20121326 A1 PE20121326 A1 PE 20121326A1 PE 2012000255 A PE2012000255 A PE 2012000255A PE 2012000255 A PE2012000255 A PE 2012000255A PE 20121326 A1 PE20121326 A1 PE 20121326A1
Authority
PE
Peru
Prior art keywords
piperidin
carboxamide
dihydro
oxo
same
Prior art date
Application number
PE2012000255A
Other languages
English (en)
Spanish (es)
Inventor
Satoshi Sasaki
Yuta Tanaka
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43627972&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20121326(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of PE20121326A1 publication Critical patent/PE20121326A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PE2012000255A 2009-08-26 2010-08-25 Derivados de anillo heterociclico fusionado y uso del mismo PE20121326A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009195770 2009-08-26
JP2010015644 2010-01-27

Publications (1)

Publication Number Publication Date
PE20121326A1 true PE20121326A1 (es) 2012-10-11

Family

ID=43627972

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012000255A PE20121326A1 (es) 2009-08-26 2010-08-25 Derivados de anillo heterociclico fusionado y uso del mismo

Country Status (24)

Country Link
US (1) US8907089B2 (enExample)
EP (1) EP2471790B1 (enExample)
JP (1) JP5599802B2 (enExample)
KR (1) KR20120078703A (enExample)
CN (1) CN102574851A (enExample)
AU (1) AU2010287492A1 (enExample)
BR (1) BR112012004134A2 (enExample)
CA (1) CA2771833A1 (enExample)
CL (1) CL2012000461A1 (enExample)
CR (1) CR20120095A (enExample)
DO (1) DOP2012000048A (enExample)
EA (1) EA201270311A1 (enExample)
EC (1) ECSP12011747A (enExample)
GE (1) GEP20146075B (enExample)
IL (1) IL218323A0 (enExample)
IN (1) IN2012DN02069A (enExample)
MA (1) MA33589B1 (enExample)
MX (1) MX2012002419A (enExample)
NZ (1) NZ598749A (enExample)
PE (1) PE20121326A1 (enExample)
SG (1) SG178504A1 (enExample)
TN (1) TN2012000084A1 (enExample)
WO (1) WO2011024872A1 (enExample)
ZA (1) ZA201201795B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2471793B1 (en) * 2009-08-26 2016-10-05 Takeda Pharmaceutical Company Limited Fused heterocyclic ring derivative and use thereof
WO2014140077A1 (en) * 2013-03-14 2014-09-18 Glaxosmithkline Intellectual Property (No.2) Limited Furopyridines as bromodomain inhibitors

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436965B1 (en) 2000-03-02 2002-08-20 Merck Frosst Canada & Co. PDE IV inhibiting amides, compositions and methods of treatment
EP1310488A4 (en) 2000-08-09 2005-08-10 Mitsubishi Pharma Corp CONDENSED BICYCLIC AMIDE COMPOUNDS AND MEDICAL USES THEREOF
CA2469435A1 (en) 2001-12-21 2003-07-24 X-Ceptor Therapeutics, Inc. Modulators of lxr
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
AU2003265853A1 (en) 2002-08-29 2004-03-19 Curis, Inc. Hedgehog antagonists, methods and uses related thereto
WO2005033288A2 (en) * 2003-09-29 2005-04-14 The Johns Hopkins University Hedgehog pathway antagonists
US20050203081A1 (en) 2004-02-25 2005-09-15 Jinbo Lee Inhibitors of protein tyrosine phosphatase 1B
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
WO2008057469A1 (en) * 2006-11-02 2008-05-15 Wyeth Small organic molecule regulators of cell proliferation
US8273747B2 (en) 2006-11-02 2012-09-25 Curis, Inc. Small organic molecule regulators of cell proliferation
LT2170860T (lt) 2007-06-29 2017-01-10 Pfizer Inc. Benzimidazolo dariniai
RU2364597C1 (ru) 2007-12-14 2009-08-20 Андрей Александрович Иващенко ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ
JP4685891B2 (ja) 2008-02-19 2011-05-18 株式会社ハネックス 分離装置
JO3259B1 (ar) 2008-02-26 2018-09-16 Takeda Pharmaceuticals Co مشتق دائري مغاير ملتحم واستخدامه
JP2010015644A (ja) 2008-07-04 2010-01-21 Fujitsu Ltd スピンドル機構、電磁変換特性評価機、および情報記憶装置
GB0900484D0 (en) 2009-01-13 2009-02-11 Angeletti P Ist Richerche Bio Therapeutic agent

Also Published As

Publication number Publication date
AU2010287492A1 (en) 2012-03-29
IL218323A0 (en) 2012-04-30
CA2771833A1 (en) 2011-03-03
GEP20146075B (en) 2014-04-10
KR20120078703A (ko) 2012-07-10
SG178504A1 (en) 2012-04-27
JP5599802B2 (ja) 2014-10-01
TN2012000084A1 (en) 2013-09-19
ECSP12011747A (es) 2012-05-30
ZA201201795B (en) 2013-05-29
DOP2012000048A (es) 2012-05-15
EA201270311A1 (ru) 2012-09-28
JPWO2011024872A1 (ja) 2013-01-31
MA33589B1 (fr) 2012-09-01
WO2011024872A1 (ja) 2011-03-03
CN102574851A (zh) 2012-07-11
EP2471790A1 (en) 2012-07-04
IN2012DN02069A (enExample) 2015-08-21
BR112012004134A2 (pt) 2017-06-20
EP2471790A4 (en) 2013-07-31
CL2012000461A1 (es) 2012-10-05
US8907089B2 (en) 2014-12-09
EP2471790B1 (en) 2015-03-18
CR20120095A (es) 2012-06-26
MX2012002419A (es) 2012-04-19
US20120220570A1 (en) 2012-08-30
NZ598749A (en) 2013-01-25

Similar Documents

Publication Publication Date Title
AR112833A2 (es) Compuestos pirazolo[1,5-a]pirimidina sustituida como inhibidores de trk cinasa
CY1123930T1 (el) Συνδυασμοι fgfr και cmet αναστολεων για τη θεραπεια του καρκινου
CY1125004T1 (el) Ετεροαρυλο υποκατεστημενες βητα-υδροξυαιθυλαμινες για χρηση στη θεραπεια της υπεργλυκαιμιας
JOP20220100A1 (ar) مركبات هتيروماتية ثنائية الحلقة مندمجة نشطة من الناحية المبيدة للآفات
CY1124086T1 (el) Παραγωγα 3-τετραζολυλ-βενζεν-1,2-δισουλφοναμιδιου ως αναστολεις μεταλλο-βητα-λακταμασης
CL2021002519A1 (es) Compuestos de diazina-amida activos como pesticidas.
PE20130306A1 (es) Morfolinopirimidinas y su uso en terapia
EA201390199A1 (ru) 2-замещенные-8-алкил-7-оксо-7,8-дигидропиридо[2,3-d]пиримидин-6-карбонитрилы и их применение
PE20190711A1 (es) N-(fenils ulfonil) benzamidas y compuestos relacionados como inhibidores de bcl-2
PE20140970A1 (es) Derivados de 6-ciclobutil-1,5-dihidro-pirazol [3,4-d) pirimidin-4-ona y su uso como inhibidores de pde9a
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
SA520411638B1 (ar) Tam أملاح لمشتقات بيرولو ترايازين مفيدة كمثبطات لـ
EA201290073A1 (ru) Соединения мочевины, содержащие 5,6-бициклический гетероарил, как ингибиторы киназ
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
PE20161066A1 (es) Derivados de piperidinil-indol como inhibidores del factor de complemento b y usos de los mismos
MX2011011875A (es) Compuesto de carboxamida heterociclica diamino.
EA201400333A1 (ru) Бензонитрильные производные в качестве ингибиторов киназ
CY1119165T1 (el) Παραγωγα βενζιμιδαζολονης ως αναστολεις βρωμοπεδιου
AR082799A1 (es) Derivados de quinolina y quinoxalina como inhibidores de quinasa
PE20181269A1 (es) Agonistas del receptor de apelina y metodos de uso
EA201200049A1 (ru) 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17
EA200801565A1 (ru) Производные пиримидиниларилмочевины в качестве ингибиторов фактора роста фибробластов ( fgf-фактора )
AR077468A1 (es) Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
EA201300282A1 (ru) Производные триазолопиразина
EA201201081A1 (ru) Производные гетарил[1,8]нафтиридина

Legal Events

Date Code Title Description
FD Application declared void or lapsed